Back

FMO2 alleviates doxorubicin-induced cardiac injury via promoting XLF-dependent DNA repair

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Basic bombshells in heart failure Cardiotoxicity of Drugs and Other Therapies ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Cheng Ni

The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou (China)

5 More presentations in this session

Presentation thumbnail
Speckle tracking detects incipient myocardial systolic dysfunction in an experimental translational animal model of HFpEF
Mr P. De Oliveira Neto (Ribeirao Preto, BR)
Abstract Slides Video
Presentation thumbnail
A soluble guanylate cyclase stimulator improves survival in a rat model of heart failure with reduced ejection fraction and chronic kidney disease induced by aorto-caval fistula and 5/6 nephrectomy
Doctor P. Kala (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
GLP-2 ameliorates HFpEF with cognitive impairment
Doctor J. Zhao (Nanjing, CN)
Abstract Slides Video
Presentation thumbnail
The novel paracrine role of cardiac FGFR1 signalling in diabetic heart failure
Miss S. Gare (Manchester, GB)
Abstract Slides Video
Presentation thumbnail
Investigating the role of protease-activated receptor 2 in adverse cardiac remodeling and clinical outcomes in heart failure: insights from translational research
Ms E. Ghanbari (Berlin, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Basic bombshells in heart failure

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Novel targets against myocardial damage
thumbnail
Congress Session
Cardiotoxicity of cancer therapies
thumbnail
Congress Session
Young Investigator Award Session in Basic and Translational Sciences

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources